Septerna Stock Surges on Oral Obesity Drug Deal With Novo Nordisk

• click to rate

  Posted by Two Blokes May 15 - Filed in Stock - 2 views
  
  SEPN is entitled to receive around $2.2 billion from NVO under the new collaboration deal, which aims to develop oral pills for obesity and other diseases.